GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anterogen Co Ltd (XKRX:065660) » Definitions » Total Operating Expense

Anterogen Co (XKRX:065660) Total Operating Expense : ₩7,745 Mil (TTM As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Anterogen Co Total Operating Expense?

Anterogen Co's Total Operating Expense for the three months ended in Mar. 2024 was ₩1,550 Mil. Anterogen Co's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₩7,745 Mil.


Anterogen Co Total Operating Expense Historical Data

The historical data trend for Anterogen Co's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anterogen Co Total Operating Expense Chart

Anterogen Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,568.61 5,455.85 6,496.28 7,264.62 7,740.20

Anterogen Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,544.58 2,554.76 2,086.97 1,553.89 1,549.60

Anterogen Co Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩7,745 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Anterogen Co Total Operating Expense Related Terms

Thank you for viewing the detailed overview of Anterogen Co's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Anterogen Co (XKRX:065660) Business Description

Traded in Other Exchanges
N/A
Address
Namsung Plaza, Gasan-dong, 405, 130, Digital-ro, Geumcheon-gu, Seoul, KOR, 08589
Anterogen Co Ltd is a bio-venture company engaged in the research and development of cell therapy products and orphan drugs using adult stem cells. Its products include Cupistem injection, Queen cell, Remodulin injection, and TheraStem-Derma. The company also offers cell banking services and analysis services that include sample analysis for clinical studies.

Anterogen Co (XKRX:065660) Headlines

No Headlines